HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:391
|
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
  • [1] HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO ALPHA-HUMAN ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    SAITO, H
    OGIHARA, T
    NAKAMARU, M
    HARA, H
    HIGAKI, J
    RAKUGI, H
    TATEYAMA, H
    MINAMINO, T
    IINUMA, K
    KUMAHARA, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) : 142 - 147
  • [2] HEMODYNAMIC, RENAL AND HORMONAL EFFECTS OF ALPHA-HUMAN ATRIAL-NATRIURETIC-PEPTIDE INJECTION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    SAITO, H
    OGIHARA, T
    NAKAMARU, M
    HARA, H
    HIGAKI, J
    IINUMA, K
    HASHIZUME, K
    RAKUGI, H
    TATEYAMA, H
    MINAMINO, T
    KUMAHARA, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (08): : 911 - 912
  • [3] HUMAN ATRIAL-NATRIURETIC-PEPTIDE - PLASMA-LEVELS, HEMODYNAMIC, HORMONAL, AND RENAL EFFECTS IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
    RIEGGER, GAJ
    KROMER, EP
    KOCHSIEK, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (06) : 1107 - 1112
  • [4] CONCENTRATIONS OF BRAIN NATRIURETIC PEPTIDE IN TREATED CONGESTIVE-HEART-FAILURE
    TOGASHI, K
    ANDO, K
    HASEGAWA, N
    KAWAKAMI, M
    MARUMO, F
    CLINICAL CHEMISTRY, 1991, 37 (05) : 765 - 765
  • [5] Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure
    Nagaya, N
    Saloh, T
    Nishikimi, T
    Uematsu, M
    Furuichi, S
    Sakamaki, F
    Oya, H
    Kyotani, S
    Nakanishi, N
    Goto, Y
    Masuda, Y
    Miyatake, K
    Kangawa, K
    CIRCULATION, 2000, 101 (05) : 498 - 503
  • [6] HEMODYNAMIC, RENAL, AND ENDOCRINE EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE IN SEVERE CONGESTIVE-HEART-FAILURE
    MOLINA, CR
    FOWLER, MB
    PETERSON, CA
    COSTARD, A
    MYERS, BD
    MURAD, F
    CLINICAL RESEARCH, 1987, 35 (03): : A642 - A642
  • [7] RENAL, HEMODYNAMIC AND HORMONAL INTERACTIONS BETWEEN ATRIAL-NATRIURETIC-FACTOR AND ARGININE VASOPRESSIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    NAKAMURA, M
    YOSHIDA, H
    FUNAKOSHI, T
    ARAKAWA, N
    HIRAMORI, K
    CLINICAL SCIENCE, 1992, 82 (04) : 363 - 368
  • [8] Renal effects of brain natriuretic peptide in patients with congestive heart failure
    Jensen, KT
    Eiskjæer, H
    Carstens, J
    Pedersen, EB
    CLINICAL SCIENCE, 1999, 96 (01) : 5 - 15
  • [9] DIFFERENT SECRETION PATTERNS OF ATRIAL-NATRIURETIC-PEPTIDE AND BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    YOSHIMURA, M
    YASUE, H
    OKUMURA, K
    OGAWA, H
    JOUGASAKI, M
    MUKOYAMA, M
    NAKAO, K
    IMURA, H
    CIRCULATION, 1993, 87 (02) : 464 - 469
  • [10] HEMODYNAMIC AND NEUROHUMORAL RESPONSES TO EXERCISE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    UEYAMA, M
    NISHIMURA, H
    KUBOTA, J
    KAWAMURA, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1993, 57 (05): : 411 - 417